Studies have shown that KLRB1 gene inactivation enhances T-cell-mediated killing of glioma cells in vitro and the anti-tumor function of KLRB1 in vivo [13], whereas decreased KLRB1 expression has been associated with poor prognosis in BC patients [11]. This evidence concerns the gene KLRB1 and glioma.